Canaccord Genuity analyst Whitney Ijem maintained a Buy rating on Passage Bio (PASG – Research Report) yesterday and set a price target ...

PHILADELPHIA, PA — Passage Bio, Inc. (Nasdaq: PASG) this week reported its third quarter financial results for 2024, ...

Passage Bio, Inc. ( (PASG)) has released its Q3 earnings. Here is a breakdown of the information Passage Bio, Inc. presented to its investors. Passage Bio, Inc. is a clinical-stage genetic medicines ...

Watertown, Mass., added millions of square feet of lab space in just a few years. Here's how it happened, and why the pace ...

PHILADELPHIA, PA — Passage Bio, Inc. (NASDAQ: PASG) announced that Will Chou, M.D., the president and chief executive officer ...

Proposition 4 funds a variety of climate-related projects, including those that focus on wildfire prevention and the protection of natural lands.

Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced the presentation of new data on two of its promising investigational ...

WARREN, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings ... One of his notable achievements was in advocating for and securing the passage of legislation in New ...

On Tuesday night, millions of Americans watched as former president Donald J. Trump gathered up enough electoral votes needed ...

Amendment 3, which proposed to legalize recreational marijuana for adults in Florida, failed to pass in the 2024 election. Although a majority of voters supported the mesure, it fell short of the 60% ...

Now, thanks to the passage of Prop KK, they have a lifeline that may help keep them open, she said. But the earliest the ...

Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell ...